Hacker News Reader

Parent Full thread

toomuchtodo

Vaccine candidate?

View on HN

There's a benign bacteria being sold to outcompete it.

What's that?

https://news.ycombinator.com/item?id=37634713

A $20k probiotic vs a $20 round of antibiotics?

> Oh, for the ship-to-your-house version in May, we're dropping the price to $250

https://twitter.com/LanternBioworks/status/17699293904048991...

Well, at that price I might be interested.

In theory, a cure vs a paliative.

That's a different species of bacteria altogether.

> That's a different species of bacteria altogether.

likely hence the "out-compete", by a different species

The bacteria in the link is Streptococcus mutans, the species in this article is Fusobacterium nucleatum. They're not the same species, one can't be used to replace the other.

It can be, if they secrete inhibitory metabolites and/or compete for the same feeding substrates.

Yes, that seems to be the case, at least in principle: https://pubmed.ncbi.nlm.nih.gov/36634619/

I'm not aware of any actual projects in development, but it could certainly be that some are in their very early stages.

Reply on news.ycombinator.com